Algorithm lowers number of CTs for some strokes
An imaging algorithm reduced the number of CT angiography and CT perfusion studies performed on patients with aneurysmal subarachnoid hemorrhages, a form of stroke.
An imaging algorithm reduced the number of CT angiography and CT perfusion studies performed on patients with aneurysmal subarachnoid hemorrhages, a form of stroke. The study was performed at New York Presbyterian Hospital – Weill Cornell Medical Center researchers and included 60 patients.
The algorithm identifies the most appropriate points at which to detect vasospasm with CT angiography and CT perfusion imaging. A flow chart establishes imaging pathways and time frames.
With the new algorithm, the mean number of CT examinations per patient dropped from 7.8 to 5.8, a decrease of 25.6%, according to the researchers. The number of CT perfusion exams per patient decreased 32.1% and overall cumulative radiation exposure decreased by 12.1%.
The results were published in the American Journal of Roentgenology (AJR 2010;195(1):176-180).
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
